Table 2B.
Demographic and Clinical Characteristics of Patients who Received a Deceased Donor Preemptive Kidney Transplant by Race/Ethnicity
| All Patients with DD Preemptive Transplant N=370 | Preemptively Transplanted with Deceased Donor, N (%) | P-value≠ | |||
|---|---|---|---|---|---|
| White 203 (54.9%) | Hispanic 101 (27.3%) | Black 66 (17.8%) | |||
| Age, Mean (SD), yrs | 10.7 ± 5.0 | 11.1 ± 5.0 | 10.0 ± 5.1 | 10.5 ± 4.9 | 0.3957 |
| Age Category, N (%), yrs | 0.3906 | ||||
| 0–5 yrs | 75 (20.3%) | 38 (18.7%) | 25 (24.8%) | 12 (18.2%) | |
| 6–10 yrs | 84 (22.7%) | 40 (19.7%) | 25 (24.8%) | 19 (28.8%) | |
| 11–17 yrs | 211 (57.0%) | 125 (61.6%) | 51 (50.5%) | 35 (53.0%) | |
| Female, N (%) | 117 (31.6%) | 69 (34.0%) | 31 (30.7%) | 17 (25.8%) | 0.4456 |
| Cause of ESRD, N (%) | 0.0820 | ||||
| GN1 | 11 (3.0%) | 2 (1.0%) | 5 (5.0%) | 4 (6.1%) | |
| Secondary GN | 1 (0.3%) | 0 (0%) | 0 (0%) | 1 (1.5%) | |
| Cystic/hereditary | 222 (60.0%) | 141 (69.5%) | 51 (50.5%) | 30 (45.4%) | |
| FSGS2 | 23 (6.2%) | 10 (4.9%) | 5 (5.0%) | 8 (12.1%) | |
| Lupus nephritis | 1 (0.3%) | 0 (0%) | 1 (1.0%) | 0 (0%) | |
| Other | 112 (30.3%) | 50 (24.6%) | 39 (38.6%) | 23 (34.9%) | |
| Organ Procurement Organization Region | 0.6768 | ||||
| 1 | 11 (3.0%) | 6 (3.0%) | 2 (2.0%) | 3 (4.6%) | |
| 2 | 56 (15.1%) | 38 (18.7%) | 7 (6.9%) | 11 (16.7%) | |
| 3 | 42 (11.4%) | 18 (8.9%) | 13 (12.9%) | 11 (16.7%) | |
| 4 | 30 (8.1%) | 11 (5.4%) | 16 (15.8%) | 3 (4.6%) | |
| 5 | 74 (20.0%) | 25 (12.3%) | 45 (44.6%) | 4 (6.1%) | |
| 6 | 9 (2.4%) | 9 (4.4%) | 0 (0%) | 0 (0%) | |
| 7 | 33 (8.9%) | 22 (10.8%) | 4 (4.0%) | 7 (10.6%) | |
| 8 | 19 (5.1%) | 17 (8.4%) | 1 (1.0%) | 1 (1.5%) | |
| 9 | 30 (8.1%) | 13 (6.4%) | 9 (8.9%) | 8 (12.1%) | |
| 10 | 20 (5.4%) | 18 (8.9%) | 1 (1.0%) | 1 (1.5%) | |
| 11 | 46 (12.4%) | 26 (12.8%) | 3 (3.0%) | 17 (25.8%) | |
| Health Insurance Coverage | <0.0001 | ||||
| Public | 195 (52.7%) | 83 (40.9%) | 74 (73.3%) | 38 (57.6%) | |
| Private | 125 (33.8%) | 102 (50.3%) | 12 (11.9%) | 11 (16.7%) | |
| Other | 45 (12.2%) | 15 (7.4%) | 13 (12.9%) | 17 (25.8%) | |
| None | 5 (1.4%) | 3 (1.5%) | 2 (2.0%) | 0 (0%) | |
| Clinical and Demographic Characteristics | |||||
| BMI > 85% 4 | 30 (8.1%) | 14 (6.9%) | 13 (12.9%) | 3 (4.6%) | 0.1003 |
| Albumin ≥ 3.5 g/dL | 120 (32.4%) | 55 (27.1%) | 40 (39.6%) | 25 (37.9%) | 0.0522 |
| Hgb ≥ 11g/dL | 250 (67.6%) | 148 (72.9%) | 61 (60.4%) | 41 (62.1%) | 0.1205 |
| Pre-dialysis ESA5 | 187 (50.5%) | 108 (53.2%) | 47 (46.5%) | 32 (48.5%) | 0.5129 |
| Neighborhood Characteristics | |||||
| Neighborhood Poverty (% zip below poverty) | <0.0001 | ||||
| 0–4.9% | 57 (15.4%) | 47 (23.2%) | 7 (6.9%) | 3 (4.6%) | |
| 5–9.9% | 112 (30.3%) | 78 (38.4%) | 18 (17.8%) | 16 (24.2%) | |
| 10–14.9% | 64 (17.3%) | 35 (17.2%) | 17 (16.8%) | 12 (18.2%) | |
| 15–19.9% | 47 (12.7%) | 19 (9.4%) | 17 (16.8%) | 11 (16.7%) | |
| > 20% | 90 (24.3%) | 24 (11.8%) | 42 (41.6%) | 24 (36.4%) | |
| Residential Urban Commuting Area | 0.0057 | ||||
| Urban | 291 (78.7%) | 146 (71.9%) | 90 (89.1%) | 55 (83.3%) | |
| Rural | 79 (21.4%) | 57 (28.1%) | 11 (10.9%) | 11 (16.7%) | |
1
Glomerulonephritis
2
Focal Segmental Glomerulosclerosis
3
Post-Sept. 2005 vs. Pre-Sept. 2005
4
Body Mass Index
5
Erythropoiesis-Stimulating Agent
≠
p-values < 0.05 for each variable indicate that at least one variable level is significantly different across racial/ethnic groups.